These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7669075)

  • 1. Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin.
    Chao CC; Gekker G; Hu S; Sheng WS; Portoghese PS; Peterson PK
    Biochem Pharmacol; 1995 Aug; 50(5):715-22. PubMed ID: 7669075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous opioid peptides suppress cytokine-mediated upregulation of HIV-1 expression in the chronically infected promonocyte clone U1.
    Chao CC; Gekker G; Sheng WS; Hu S; Portoghese PS; Peterson PK
    Adv Exp Med Biol; 1995; 373():65-72. PubMed ID: 7668162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells.
    Peterson PK; Gekker G; Hu S; Anderson WR; Kravitz F; Portoghese PS; Balfour HH; Chao CC
    J Neuroimmunol; 1994 Mar; 50(2):167-75. PubMed ID: 8120138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.
    Granowitz EV; Saget BM; Angel JB; Wang MZ; Wang A; Dinarello CA; Skolnik PR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):430-7. PubMed ID: 8605587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
    Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa-opioid potentiation of tumor necrosis factor-alpha-induced anti-HIV-1 activity in acutely infected human brain cell cultures.
    Chao CC; Gekker G; Hu S; Kravitz F; Peterson PK
    Biochem Pharmacol; 1998 Aug; 56(3):397-404. PubMed ID: 9744578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression.
    Chao CC; Gekker G; Hu S; Sheng WS; Shark KB; Bu DF; Archer S; Bidlack JM; Peterson PK
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):8051-6. PubMed ID: 8755601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-melanocyte-stimulating hormone peptides inhibit HIV-1 expression in chronically infected promonocytic U1 cells and in acutely infected monocytes.
    Barcellini W; Colombo G; La Maestra L; Clerici G; Garofalo L; Brini AT; Lipton JM; Catania A
    J Leukoc Biol; 2000 Nov; 68(5):693-9. PubMed ID: 11073109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell cytokine production stimulates HIV-1 expression in chronically HIV-1-infected monocytes.
    O'Donnell MP; Chao CC; Gekker G; Modi KS; Kasiske BL; Keane WF
    Kidney Int; 1998 Mar; 53(3):593-7. PubMed ID: 9507203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage.
    Finnegan A; Roebuck KA; Nakai BE; Gu DS; Rabbi MF; Song S; Landay AL
    J Immunol; 1996 Jan; 156(2):841-51. PubMed ID: 8543841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 and glucocorticoids synergistically induce human immunodeficiency virus type-1 expression in chronically infected U1 cells by a long terminal repeat independent post-transcriptional mechanism.
    Kinter AL; Biswas P; Alfano M; Justement JS; Mantelli B; Rizzi C; Gatti AR; Vicenzi E; Bressler P; Poli G
    Mol Med; 2001 Oct; 7(10):668-78. PubMed ID: 11713366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist.
    Poli G; Kinter AL; Fauci AS
    Proc Natl Acad Sci U S A; 1994 Jan; 91(1):108-12. PubMed ID: 7506410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism.
    Angel JB; Saget BM; Wang MZ; Wang A; Dinarello CA; Skolnik PR
    J Interferon Cytokine Res; 1995 Jun; 15(6):575-84. PubMed ID: 7553227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-8 fails to induce human immunodeficiency virus-1 expression in chronically infected promonocytic U1 cells but differentially modulates induction by proinflammatory cytokines.
    Tiemessen CT; Kilroe B; Martin DJ
    Immunology; 2000 Sep; 101(1):140-6. PubMed ID: 11012765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous kappa-opioid receptor agonist.
    Hiramatsu M; Murasawa H; Mori H; Kameyama T
    Br J Pharmacol; 1998 Mar; 123(5):920-6. PubMed ID: 9535021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures.
    Kong LY; McMillian MK; Hudson PM; Jin L; Hong JS
    J Pharmacol Exp Ther; 1997 Jan; 280(1):61-6. PubMed ID: 8996182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage.
    Weissman D; Poli G; Fauci AS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):442-9. PubMed ID: 7627621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
    Li JG; Zhang F; Jin XL; Liu-Chen LY
    J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.